237 related articles for article (PubMed ID: 22624717)
1. In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma.
Ignatius MS; Chen E; Elpek NM; Fuller AZ; Tenente IM; Clagg R; Liu S; Blackburn JS; Linardic CM; Rosenberg AE; Nielsen PG; Mempel TR; Langenau DM
Cancer Cell; 2012 May; 21(5):680-693. PubMed ID: 22624717
[TBL] [Abstract][Full Text] [Related]
2. The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma.
Ignatius MS; Hayes MN; Lobbardi R; Chen EY; McCarthy KM; Sreenivas P; Motala Z; Durbin AD; Molodtsov A; Reeder S; Jin A; Sindiri S; Beleyea BC; Bhere D; Alexander MS; Shah K; Keller C; Linardic CM; Nielsen PG; Malkin D; Khan J; Langenau DM
Cell Rep; 2017 Jun; 19(11):2304-2318. PubMed ID: 28614716
[TBL] [Abstract][Full Text] [Related]
3. Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness.
Chiappalupi S; Riuzzi F; Fulle S; Donato R; Sorci G
Carcinogenesis; 2014 Oct; 35(10):2382-92. PubMed ID: 25123133
[TBL] [Abstract][Full Text] [Related]
4. A dysfunctional miR-1-TRPS1-MYOG axis drives ERMS by suppressing terminal myogenic differentiation.
Hüttner SS; Henze H; Elster D; Koch P; Anderer U; von Eyss B; von Maltzahn J
Mol Ther; 2023 Sep; 31(9):2612-2632. PubMed ID: 37452493
[TBL] [Abstract][Full Text] [Related]
5. Effects of RAS on the genesis of embryonal rhabdomyosarcoma.
Langenau DM; Keefe MD; Storer NY; Guyon JR; Kutok JL; Le X; Goessling W; Neuberg DS; Kunkel LM; Zon LI
Genes Dev; 2007 Jun; 21(11):1382-95. PubMed ID: 17510286
[TBL] [Abstract][Full Text] [Related]
6. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice.
Nitzki F; Zibat A; Frommhold A; Schneider A; Schulz-Schaeffer W; Braun T; Hahn H
Oncogene; 2011 Oct; 30(43):4428-36. PubMed ID: 21602886
[TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma.
Vleeshouwer-Neumann T; Phelps M; Bammler TK; MacDonald JW; Jenkins I; Chen EY
PLoS One; 2015; 10(12):e0144320. PubMed ID: 26636678
[TBL] [Abstract][Full Text] [Related]
8.
Ignatius MS; Hayes MN; Moore FE; Tang Q; Garcia SP; Blackburn PR; Baxi K; Wang L; Jin A; Ramakrishnan A; Reeder S; Chen Y; Nielsen GP; Chen EY; Hasserjian RP; Tirode F; Ekker SC; Langenau DM
Elife; 2018 Sep; 7():. PubMed ID: 30192230
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.
Chen EY; DeRan MT; Ignatius MS; Grandinetti KB; Clagg R; McCarthy KM; Lobbardi RM; Brockmann J; Keller C; Wu X; Langenau DM
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5349-54. PubMed ID: 24706870
[TBL] [Abstract][Full Text] [Related]
10. CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG.
Liu Z; Zhang X; Lei H; Lam N; Carter S; Yockey O; Xu M; Mendoza A; Hernandez ER; Wei JS; Khan J; Yohe ME; Shern JF; Thiele CJ
Nat Commun; 2020 Feb; 11(1):911. PubMed ID: 32060262
[TBL] [Abstract][Full Text] [Related]
11. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
Kouraklis G; Triche TJ; Wesley R; Tsokos M
Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
[TBL] [Abstract][Full Text] [Related]
12. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
[TBL] [Abstract][Full Text] [Related]
13. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
[TBL] [Abstract][Full Text] [Related]
14. Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.
Singh S; Vinson C; Gurley CM; Nolen GT; Beggs ML; Nagarajan R; Wagner EF; Parham DM; Peterson CA
Am J Pathol; 2010 Oct; 177(4):2055-66. PubMed ID: 20829439
[TBL] [Abstract][Full Text] [Related]
15. Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma.
Tenente IM; Hayes MN; Ignatius MS; McCarthy K; Yohe M; Sindiri S; Gryder B; Oliveira ML; Ramakrishnan A; Tang Q; Chen EY; Petur Nielsen G; Khan J; Langenau DM
Elife; 2017 Jan; 6():. PubMed ID: 28080960
[TBL] [Abstract][Full Text] [Related]
16. Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4.
Nanni P; Nicoletti G; Palladini A; Astolfi A; Rinella P; Croci S; Landuzzi L; Monduzzi G; Stivani V; Antognoli A; Murgo A; Ianzano M; De Giovanni C; Lollini PL
Mol Cancer Ther; 2009 Apr; 8(4):754-61. PubMed ID: 19372547
[TBL] [Abstract][Full Text] [Related]
17. RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation.
Riuzzi F; Sorci G; Sagheddu R; Sidoni A; Alaggio R; Ninfo V; Donato R
J Cell Sci; 2014 Apr; 127(Pt 8):1699-711. PubMed ID: 24554430
[TBL] [Abstract][Full Text] [Related]
18. Cross-species array comparative genomic hybridization identifies novel oncogenic events in zebrafish and human embryonal rhabdomyosarcoma.
Chen EY; Dobrinski KP; Brown KH; Clagg R; Edelman E; Ignatius MS; Chen JY; Brockmann J; Nielsen GP; Ramaswamy S; Keller C; Lee C; Langenau DM
PLoS Genet; 2013 Aug; 9(8):e1003727. PubMed ID: 24009521
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
Megiorni F; Gravina GL; Camero S; Ceccarelli S; Del Fattore A; Desiderio V; Papaccio F; McDowell HP; Shukla R; Pizzuti A; Beirinckx F; Pujuguet P; Saniere L; der Aar EV; Maggio R; De Felice F; Marchese C; Dominici C; Tombolini V; Festuccia C; Marampon F
J Hematol Oncol; 2017 Oct; 10(1):161. PubMed ID: 28985758
[TBL] [Abstract][Full Text] [Related]
20. Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens.
Hostein I; Andraud-Fregeville M; Guillou L; Terrier-Lacombe MJ; Deminière C; Ranchère D; Lussan C; Longavenne E; Bui NB; Delattre O; Coindre JM
Cancer; 2004 Dec; 101(12):2817-24. PubMed ID: 15536621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]